Table 3.
Continuous traits Significantly associated with NT5C using AstraZeneca PheWAS portal
| Phenotype | Collapsing model | Phenotypic category | P value | No. samples | Effect size | Effect size standard error | Effect size LCI | Effect size UCI |
| 1072#1906#NT5C#Q8TCD5#OID30294#v1#CardiometabolicII | flexdmg | OLINK Proteomics | 2.40E-37 | 45616 | -1.534198395 | 0.120029789 | -1.769458705 | -1.298938086 |
| 1072#1906#NT5C#Q8TCD5#OID30294#v1#CardiometabolicII | flexnonsynmtr | OLINK Proteomics | 2.63E-19 | 45616 | -1.23465192 | 0.137378543 | -1.503916064 | -0.965387776 |
| 1072#1906#NT5C#Q8TCD5#OID30294#v1#CardiometabolicII | ptv | OLINK Proteomics | 1.28E-11 | 45616 | -1.245853126 | 0.183948058 | -1.606394265 | -0.885311987 |
| 1072#1906#NT5C#Q8TCD5#OID30294#v1#CardiometabolicII | ptv5pcnt | OLINK Proteomics | 1.28E-11 | 45616 | -1.245853126 | 0.183948058 | -1.606394265 | -0.885311987 |
| 1072#1906#NT5C#Q8TCD5#OID30294#v1#CardiometabolicII | ptvraredmg | OLINK Proteomics | 2.40E-37 | 45616 | -1.534198395 | 0.120029789 | -1.769458705 | -1.298938086 |
| 1072#1906#NT5C#Q8TCD5#OID30294#v1#CardiometabolicII | raredmg | OLINK Proteomics | 2.38E-27 | 45616 | -1.764394097 | 0.162755079 | -2.083396658 | -1.445391536 |